Ciproplit DB Eye Drops: Ciprofloxacin Dexamethasone Combo Therapy

Dual Mechanism: Eliminating Bacteria While Reducing Swelling and Redness

Key Indications: Treating Severe Bacterial Conjunctivitis and Keratitis

Component Roles: Antibiotic Action vs Anti-inflammatory Benefits

Administration and Safety: The Importance of Preservative Benzalkonium Chloride
Secure Your Territory: Ciproplit DB PCD Pharma Franchise Opportunity

Home/Products /ciprofloxacin-hydrochloride-sodium-phosphate-w-v-benzalkoniumchloride-solution-eye-drop

Ciproplit DB Eye Drops

Composition : Ciprofloxacin Hydrochloride IP 0.3%w/v + Dexamethasone Sodium Phosphate IP 0.01% w/v + BenzalkoniumChloride Solution IP 0.02%v/v Eye Drop

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹1/-

Ciproplit DB Eye Drops offer a powerful, synergistic solution for managing bacterial eye infections that are accompanied by significant inflammation. The formulation uniquely combines two active pharmaceutical ingredients: Ciprofloxacin Hydrochloride 0.3% and Dexamethasone Sodium Phosphate 0.01%.

Mechanism and Impact:Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase, quickly killing the infectious organisms. Dexamethasone is a potent corticosteroid that suppresses the inflammatory response, reducing redness, swelling, and pain. This combination is essential because it treats both the cause (bacteria) and the symptoms (inflammation) simultaneously, promoting faster healing and improved patient comfort. The presence of Benzalkonium Chloride ensures product sterility during use.

Key Therapeutic Uses:

  • Infected and Inflamed Eyes: Standard treatment for acute conditions like severe bacterial conjunctivitis.

  • Post-operative Care: Used to prevent infection and manage inflammation following ocular surgery.

We offer an exclusive PCD Pharma Franchise opportunity for Ciproplit DB Eye Drops, a staple product in acute ophthalmic care, ensuring consistent demand.

Read More

About the Product

Ciproplit DB Eye Drops offer a powerful, synergistic solution for managing bacterial eye infections that are accompanied by significant inflammation. The formulation uniquely combines two active pharmaceutical ingredients: Ciprofloxacin Hydrochloride 0.3% and Dexamethasone Sodium Phosphate 0.01%.

Mechanism and Impact:Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic that works by inhibiting bacterial DNA gyrase, quickly killing the infectious organisms. Dexamethasone is a potent corticosteroid that suppresses the inflammatory response, reducing redness, swelling, and pain. This combination is essential because it treats both the cause (bacteria) and the symptoms (inflammation) simultaneously, promoting faster healing and improved patient comfort. The presence of Benzalkonium Chloride ensures product sterility during use.

Key Therapeutic Uses:

  • Infected and Inflamed Eyes: Standard treatment for acute conditions like severe bacterial conjunctivitis.

  • Post-operative Care: Used to prevent infection and manage inflammation following ocular surgery.

We offer an exclusive PCD Pharma Franchise opportunity for Ciproplit DB Eye Drops, a staple product in acute ophthalmic care, ensuring consistent demand.

Common, mild side effects may include brief eye irritation, slight discomfort, or a temporary burning sensation upon application.

Moxolunic BF Eye Drop (BAK Free) Indicated for treating bacterial eye infections, reducing post-surgical pain, redness, and swelling, and alleviating associated itching and discomfort.

Information regarding the use of Moxolunic BF Eye Drop (BAK Free) during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place at room temperature (15°C to 25°C). Keep the bottle tightly closed and away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation